Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Headache in schizophrenic patients: a controlled study.

A Kuritzky1, D Mazeh, A Levi

  • 1Department of Neurology, Rabin Medical Center, Petach Tikva, Israel. kuritzky@inter.net.il

Cephalalgia : an International Journal of Headache
|November 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Drawing improves memory in patients with hippocampal damage.

Memory & cognition·2024
Same author

Percutaneous ethanol sclerotherapy is a promising treatment for recalcitrant angiolymphoid hyperplasia with eosinophilia.

Clinical and experimental dermatology·2021
Same author

Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials.

Respiratory medicine and research·2021
Same author

Agminated benign vascular tumour successfully treated with trametinib.

The British journal of dermatology·2021
Same author

Post acne scars treatment - do picosecond lasers offer a superior non-ablative modality?

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same journal

Cerebrovascular risk with calcitonin gene-related peptide monoclonal antibodies versus onabotulinumtoxinA in patients with migraine: A real-world pharmacoepidemiologic study in the National Institutes of Health All of Us Research Program.

Cephalalgia : an international journal of headache·2026
Same journal

Burning mouth syndrome and oral dysaesthetic/perceptual symptoms: Toward clinically actionable boundaries.

Cephalalgia : an international journal of headache·2026
Same journal

Effectiveness and clinical predictors of rimegepant for acute vertigo in vestibular migraine: A real-world cohort study.

Cephalalgia : an international journal of headache·2026
Same journal

Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trial.

Cephalalgia : an international journal of headache·2026
Same journal

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

Cephalalgia : an international journal of headache·2026
Same journal

Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality.

Cephalalgia : an international journal of headache·2026
See all related articles

Chronic schizophrenic patients report headaches similarly to the general population but tend to underreport them. Despite similar headache characteristics, patients may avoid complaining, even when able to describe symptoms precisely.

Area of Science:

  • Neurology
  • Psychiatry
  • Clinical Psychology

Background:

  • Previous research suggests a lower incidence of headaches in chronic schizophrenic patients.
  • Headache symptomatology in schizophrenia requires further investigation.

Purpose of the Study:

  • To compare headache characteristics between chronic schizophrenic patients and a normal population.
  • To investigate potential differences in headache reporting and description.

Main Methods:

  • A questionnaire on headache symptomatology was administered to 108 chronic schizophrenic patients and 100 normal subjects.
  • Data collected included headache type, location, frequency, severity, duration, and accompanying phenomena.

Main Results:

Related Experiment Videos

  • Both groups reported headaches with high frequency, showing no significant differences in most parameters.
  • Schizophrenic patients demonstrated a tendency to underreport headaches despite their ability to describe them accurately.
  • No correlation was identified between headache type and schizophrenia type.

    • Conclusions:

    • Chronic schizophrenic patients experience headaches comparable to the general population but may exhibit a reluctance to report them.
    • The findings highlight the importance of exploring subjective symptom reporting in psychiatric populations.
    • Further research is needed to understand the nuances of pain perception and reporting in schizophrenia.